ATE399854T1 - HÄMATOPOETISCHE ßFACILITATORYß-ZELLEN UND IHRE VERWENDUNG - Google Patents
HÄMATOPOETISCHE ßFACILITATORYß-ZELLEN UND IHRE VERWENDUNGInfo
- Publication number
- ATE399854T1 ATE399854T1 AT93918173T AT93918173T ATE399854T1 AT E399854 T1 ATE399854 T1 AT E399854T1 AT 93918173 T AT93918173 T AT 93918173T AT 93918173 T AT93918173 T AT 93918173T AT E399854 T1 ATE399854 T1 AT E399854T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- bone marrow
- marrow cells
- hematopoietic
- engraftment
- Prior art date
Links
- 210000002798 bone marrow cell Anatomy 0.000 abstract 4
- 210000004027 cell Anatomy 0.000 abstract 3
- 230000003394 haemopoietic effect Effects 0.000 abstract 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 abstract 2
- 210000000056 organ Anatomy 0.000 abstract 2
- 210000001519 tissue Anatomy 0.000 abstract 2
- 206010068051 Chimerism Diseases 0.000 abstract 1
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 1
- 206010061598 Immunodeficiency Diseases 0.000 abstract 1
- 208000029462 Immunodeficiency disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
- 230000005784 autoimmunity Effects 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 238000010322 bone marrow transplantation Methods 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 230000000494 facilitatory effect Effects 0.000 abstract 1
- 208000024908 graft versus host disease Diseases 0.000 abstract 1
- 230000007813 immunodeficiency Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 230000000998 lymphohematopoietic effect Effects 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46434—Antigens related to induction of tolerance to non-self
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91198992A | 1992-07-10 | 1992-07-10 | |
| US99654492A | 1992-12-24 | 1992-12-24 | |
| US6931593A | 1993-05-28 | 1993-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE399854T1 true ATE399854T1 (de) | 2008-07-15 |
Family
ID=27371514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93918173T ATE399854T1 (de) | 1992-07-10 | 1993-07-09 | HÄMATOPOETISCHE ßFACILITATORYß-ZELLEN UND IHRE VERWENDUNG |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0652943B1 (de) |
| JP (1) | JP3917652B2 (de) |
| AT (1) | ATE399854T1 (de) |
| AU (1) | AU688734B2 (de) |
| CA (1) | CA2139877C (de) |
| DE (1) | DE69334227D1 (de) |
| DK (1) | DK0652943T3 (de) |
| ES (1) | ES2309985T3 (de) |
| HK (1) | HK1010739A1 (de) |
| NZ (2) | NZ255039A (de) |
| PT (1) | PT652943E (de) |
| SG (1) | SG55145A1 (de) |
| WO (1) | WO1994001534A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69533504D1 (de) * | 1994-01-05 | 2004-10-21 | Univ Pittsburgh Pittsburgh | Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden |
| AU4254396A (en) * | 1994-11-14 | 1996-06-06 | Novartis Ag | Methods of inducing cell death of primitive hematopoietic cells and compositions for induction thereof |
| EP1015043A1 (de) * | 1997-09-10 | 2000-07-05 | Emory University | Verfahren, die abtossung von transplantiertem gewebe mit knocchenimplantaat zu verhindern |
| ZA200704252B (en) | 2004-10-25 | 2009-09-30 | Cellerant Therapeutics Inc | Methods of expanding myeloid cell populations and uses thereof |
| AU2007214468B2 (en) | 2006-02-14 | 2013-04-04 | Cellerant Therapeutics, Inc. | Methods and compositions for enhancing engraftment of hematopoietic stem cells |
| US8632768B2 (en) * | 2008-05-30 | 2014-01-21 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
| JP6401445B2 (ja) * | 2013-10-10 | 2018-10-10 | 国立大学法人 東京大学 | 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| DE69232427T2 (de) * | 1991-11-05 | 2002-11-21 | Univ Leland Stanford Junior | Suppressorzellen |
-
1993
- 1993-07-09 SG SG1996007923A patent/SG55145A1/en unknown
- 1993-07-09 EP EP93918173A patent/EP0652943B1/de not_active Expired - Lifetime
- 1993-07-09 ES ES93918173T patent/ES2309985T3/es not_active Expired - Lifetime
- 1993-07-09 AU AU47717/93A patent/AU688734B2/en not_active Expired
- 1993-07-09 WO PCT/US1993/006506 patent/WO1994001534A1/en active Application Filing
- 1993-07-09 PT PT93918173T patent/PT652943E/pt unknown
- 1993-07-09 DK DK93918173T patent/DK0652943T3/da active
- 1993-07-09 AT AT93918173T patent/ATE399854T1/de active
- 1993-07-09 NZ NZ255039A patent/NZ255039A/en not_active IP Right Cessation
- 1993-07-09 JP JP50354894A patent/JP3917652B2/ja not_active Expired - Lifetime
- 1993-07-09 CA CA002139877A patent/CA2139877C/en not_active Expired - Lifetime
- 1993-07-09 DE DE69334227T patent/DE69334227D1/de not_active Expired - Lifetime
-
1995
- 1995-01-24 NZ NZ299935A patent/NZ299935A/en unknown
-
1998
- 1998-10-29 HK HK98111586A patent/HK1010739A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0652943T3 (da) | 2008-11-03 |
| EP0652943A1 (de) | 1995-05-17 |
| NZ299935A (en) | 2000-07-28 |
| JPH08500009A (ja) | 1996-01-09 |
| WO1994001534A1 (en) | 1994-01-20 |
| EP0652943A4 (de) | 1996-02-07 |
| ES2309985T3 (es) | 2008-12-16 |
| SG55145A1 (en) | 1998-12-21 |
| JP3917652B2 (ja) | 2007-05-23 |
| PT652943E (pt) | 2008-10-09 |
| AU4771793A (en) | 1994-01-31 |
| DE69334227D1 (de) | 2008-08-14 |
| NZ255039A (en) | 1997-03-24 |
| CA2139877A1 (en) | 1994-01-20 |
| AU688734B2 (en) | 1998-03-19 |
| CA2139877C (en) | 2006-09-19 |
| EP0652943B1 (de) | 2008-07-02 |
| HK1010739A1 (en) | 1999-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Luria et al. | Bone formation in organ cultures of bone marrow | |
| Nade et al. | Decalcified bone as a substrate for osteogenesis. An appraisal of the interrelation of bone and marrow in combined grafts | |
| Lawler et al. | Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin | |
| NO20035637L (no) | Karbonmonoksyd forbedrer resultatene av vev og organ transplantater og undertrykker apoptose | |
| HUP9903072A2 (hu) | 5,7-Dihidroxi-kromán-4-on-származékok az immunválasz elnyomására | |
| DK1131096T3 (da) | Anti-CD20-antistofbehandling af patienter, der modtager knoglemarvs- eller periferisk blodstamcelletransplantationer | |
| MD1444B2 (ro) | Metode de inducere a toleranţei celulelor T faţă de un transplant de organe sau ţesuturi | |
| DE60129007D1 (de) | Vermehrung des weich- sowie des knochengewebes anhand von aus muskeln stammenden vorläuferzellen, sowie damit verbundene zusammensetzungen und behandlungsformen | |
| EP1153924A3 (de) | Substutuierte 1,3-Oxathiolane mit antiviralen Eigenschaften | |
| WO2002040049A3 (en) | Blockade of t cell migration into epithelial gvhd target tissues | |
| WO2000015247A8 (en) | Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists | |
| HUS1900041I1 (hu) | Treoszulfán alkalmazása betegek csontvelõ- és vér õssejt-transzplantáció elõtti kondicionálására | |
| IL118167A0 (en) | Pyrazolo (1,5a) pyrimidines their preparation and use | |
| CA2213322A1 (en) | Thiols to promote hematopoietic progenitor cell growth | |
| ATE399854T1 (de) | HÄMATOPOETISCHE ßFACILITATORYß-ZELLEN UND IHRE VERWENDUNG | |
| HK1023599A1 (en) | Cells for preventing graft rejection in transplantation and their uses. | |
| WO2002040640A3 (en) | Methods of using cd8+/tcr- facilitating cells (fc) for the engraftment of purified hematopoietic stem cells (hsc) | |
| IL116231A0 (en) | Dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals | |
| NZ515025A (en) | Solvates of pymetrozine | |
| Gorin et al. | High dose combination chemotherapy (TACC) with and without autologous bone marrow transplantation for the treatment of acute leukaemia and other malignant diseases: Kinetics of recovery of haemopoiesis. A preliminary study of 12 cases | |
| WO1999061589A3 (en) | Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof | |
| WO2003029432A3 (en) | Human mesenchymal progenitor cell | |
| Bullorsky et al. | Acute megakaryoblastic leukemia with massive myelofibrosis: complete remission and reversal of marrow fibrosis with allogeneic bone marrow transplantation as the only treatment | |
| Anwar et al. | Therapeutic potential of umbilical cord stem cells for liver regeneration | |
| MX9304187A (es) | Celulas facilitatorias hematopoyeticas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0652943 Country of ref document: EP |